These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11481312)

  • 1. Antibiotic resistance in Burkholderia cepacia at two regional cystic fibrosis centres in Northern Ireland: is there a need for synergy testing?
    Moore JE; Crowe M; Shaw A; McCaughan J; Redmond AO; Elborn JS
    J Antimicrob Chemother; 2001 Aug; 48(2):319-21. PubMed ID: 11481312
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of the E test to assess synergy of antibiotic combinations against isolates of Burkholderia cepacia-complex from patients with cystic fibrosis.
    Manno G; Ugolotti E; Belli ML; Fenu ML; Romano L; Cruciani M
    Eur J Clin Microbiol Infect Dis; 2003 Jan; 22(1):28-34. PubMed ID: 12582741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burkholderia cepacia infections in cystic fibrosis.
    Burns JL; Saiman L
    Pediatr Infect Dis J; 1999 Feb; 18(2):155-6. PubMed ID: 10048690
    [No Abstract]   [Full Text] [Related]  

  • 4. Susceptibility of multiresistant strains of Burkholderia cepacia to honey.
    Cooper RA; Wigley P; Burton NF
    Lett Appl Microbiol; 2000 Jul; 31(1):20-4. PubMed ID: 10886608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland.
    Pitt TL; Kaufmann ME; Patel PS; Benge LC; Gaskin S; Livermore DM
    J Med Microbiol; 1996 Mar; 44(3):203-10. PubMed ID: 8636938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The epidemiology of Burkholderia cepacia in cystic fibrosis patients: the initial results of a study including the genotypic typing of the strains isolated].
    Villari P; Iacuzio L; Vozzella EA; Raia V; Torre I
    Ann Ig; 1999; 11(6):501-6. PubMed ID: 10596443
    [No Abstract]   [Full Text] [Related]  

  • 7. [Isolation frequency of Burkholderia cepacia from cystic fibrosis patients].
    Ocak F; Gözalan A; Ozçelik U; Anadol D; Kiper N; Aktepe OC; Göçmen A; Esen B
    Mikrobiyol Bul; 2002 Jan; 36(1):1-10. PubMed ID: 12476760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temocillin in the treatment of Burkholderia cepacia infection in cystic fibrosis.
    Lekkas A; Gyi KM; Hodson ME
    J Cyst Fibros; 2006 May; 5(2):121-4. PubMed ID: 16650744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the role of matrix components in protection of Burkholderia cepacia complex biofilms against tobramycin.
    Messiaen AS; Nelis H; Coenye T
    J Cyst Fibros; 2014 Jan; 13(1):56-62. PubMed ID: 23932109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.
    Horsley A; Jones AM
    Cochrane Database Syst Rev; 2012 Oct; 10():CD009529. PubMed ID: 23076960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis.
    Zhou J; Chen Y; Tabibi S; Alba L; Garber E; Saiman L
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1085-8. PubMed ID: 17158942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal outcome of lung transplantation in cystic fibrosis patients due to small-colony variants of the Burkholderia cepacia complex.
    Häussler S; Lehmann C; Breselge C; Rohde M; Classen M; Tümmler B; Vandamme P; Steinmetz I
    Eur J Clin Microbiol Infect Dis; 2003 Apr; 22(4):249-53. PubMed ID: 12687415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nosocomial Acquisition of Burkholderia gladioli in patients with cystic fibrosis.
    Clode FE; Metherell LA; Pitt TL
    Am J Respir Crit Care Med; 1999 Jul; 160(1):374-5. PubMed ID: 10390428
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia.
    Aaron SD; Ferris W; Henry DA; Speert DP; Macdonald NE
    Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1206-12. PubMed ID: 10764313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case 1: assessment. Burkholderia cepacia.
    Speert DP
    Paediatr Respir Rev; 2002 Sep; 3(3):273-4. PubMed ID: 12376068
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk factors for Burkholderia cepacia complex colonization and infection among patients with cystic fibrosis.
    Walsh NM; Casano AA; Manangan LP; Sinkowitz-Cochran RL; Jarvis WR
    J Pediatr; 2002 Oct; 141(4):512-7. PubMed ID: 12378190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradication therapy for Burkholderia cepacia complex in people with cystic fibrosis.
    Regan KH; Bhatt J
    Cochrane Database Syst Rev; 2014 Oct; (10):CD009876. PubMed ID: 25342425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sugar sweet and deadly?
    Reid DW; Bell SC
    Microbiology (Reading); 2009 Mar; 155(Pt 3):665-666. PubMed ID: 19246736
    [No Abstract]   [Full Text] [Related]  

  • 19. Empiric treatment of multidrug-resistant Burkholderia cepacia lung exacerbation in a patient with cystic fibrosis: application of pharmacodynamic concepts to meropenem therapy.
    Kuti JL; Moss KM; Nicolau DP; Knauft RF
    Pharmacotherapy; 2004 Nov; 24(11):1641-5. PubMed ID: 15537567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans.
    Mahenthiralingam E; Vandamme P; Campbell ME; Henry DA; Gravelle AM; Wong LT; Davidson AG; Wilcox PG; Nakielna B; Speert DP
    Clin Infect Dis; 2001 Nov; 33(9):1469-75. PubMed ID: 11588691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.